|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-1-1
|
|
pubmed:abstractText |
Nephrotoxicity is a major side effect of calcineurin inhibitors (CNI). Earlier we reported 8% of our heart transplant recipients reaching end-stage renal failure (ESRF). Now, with an extended follow up of 20 years, we re-evaluated the development of ESRF and studied its influence on survival and the impact of polymorphisms in codon 10 and 25 of the promoter region of transforming growth factor (TGF)-beta on the risk of ESRF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1744-8
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:17198270-Adolescent,
pubmed-meshheading:17198270-Adult,
pubmed-meshheading:17198270-Aged,
pubmed-meshheading:17198270-Calcineurin,
pubmed-meshheading:17198270-Child,
pubmed-meshheading:17198270-Child, Preschool,
pubmed-meshheading:17198270-Female,
pubmed-meshheading:17198270-Heart Transplantation,
pubmed-meshheading:17198270-Humans,
pubmed-meshheading:17198270-Immunosuppressive Agents,
pubmed-meshheading:17198270-Kidney Failure, Chronic,
pubmed-meshheading:17198270-Male,
pubmed-meshheading:17198270-Middle Aged,
pubmed-meshheading:17198270-Polymorphism, Genetic,
pubmed-meshheading:17198270-Transforming Growth Factor beta1
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation.
|
|
pubmed:affiliation |
Department of Internal Medicine, Erasmus MC, University Hospital Rotterdam, the Netherlands. j.vandewetering.1@erasmusmc.nl
|
|
pubmed:publicationType |
Journal Article
|
